Citation: Sj. Hackett et al., Cytokines, chemokines and other effector molecules involved in meningococcal disease, J MED MICRO, 50(10), 2001, pp. 847-859
Authors:
Carrol, ED
Thomson, APJ
Riordan, FAI
Fellick, JM
Shears, P
Sills, JA
Hart, CA
Citation: Ed. Carrol et al., Increasing microbiological confirmation and changing epidemiology of meningococcal disease on Merseyside, England, CL MICRO IN, 6(5), 2000, pp. 259-262
Authors:
Carrol, ED
Thomson, APJ
Shears, P
Gray, SJ
Kaczmarski, EB
Hart, CA
Citation: Ed. Carrol et al., Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease, ARCH DIS CH, 83(3), 2000, pp. 271-273
Authors:
Baines, PB
Stanford, S
Bishop-Bailey, D
Sills, JA
Thomson, APJ
Mitchell, JA
Fear, SC
Hart, CA
Petros, AJ
Citation: Pb. Baines et al., Nitric oxide production in meningococcal disease is directly related to disease severity, CRIT CARE M, 27(6), 1999, pp. 1187-1190
Authors:
Riordan, FAI
Thomson, APJ
Ratcliffe, JM
Sills, JA
Diver, MJ
Hart, A
Citation: Fai. Riordan et al., Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency?, CRIT CARE M, 27(10), 1999, pp. 2257-2261
Citation: Apj. Thomson et al., Autosomal dominant optic atrophy with unilateral facial palsy: a new hereditary condition?, J MED GENET, 36(3), 1999, pp. 251-252
Authors:
Carrol, ED
Riordan, FAI
Thomson, APJ
Sills, JA
Hart, CA
Citation: Ed. Carrol et al., The role of the Glasgow meningococcal septicaemia prognostic score in the emergency management of meningococcal disease, ARCH DIS CH, 81(3), 1999, pp. 281-281